Gynecology, Obstetrics & Reproductive Health

About Conference

The EuroSciCon is a renowned organization that organizes highly momentous conferences throughout the globe. Currently, we are bringing forth “Annual conference on "Gynaecology, Obstetrics & Reproductive Health" scheduled to be held during Aug 23-24, 2018 at Amsterdam, Netherlands. The conference highlights the theme "Technical Strategies in Pre-natal grief, Child Birth and Congenital Disorders".

Euro Gynecology 2018 conference is the platform to discuss various disciplines involved in the with women's complaints—gynaecological diseases, fertility, pregnancy, contraception, etc. Gynaecology is the medical practice dealing with the health of the female reproductive systems (vagina, uterus, and ovaries) and the breasts. Almost all modern gynaecologists are also obstetricians.

Why to attend??

The scientific program includes Keynote & Plenary talks, Video Presentations, Poster Presentations and E-Posters. Furthermore, oral communications of (post) doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, and receive name recognition in this 2-day event. It is an idiosyncratic Opportunity for Advertisers and Sponsors at this International event.

The Euro Gynecology 2018 highlights the evolving strategies and conditions deals with the Cancer and pre-cancerous diseases of the reproductive organs including ovaries, fallopian tubes, uterus, cervix, vagina, and vulva.

What’s New

Euro Gynecology 2018 Conference conduct presentations, distribute information, throughout the world where we can meet with current and potential professors, researches, scientists. scientific events are the specially designed cluster of the program that provides a common platform where industry meets academia to discuss the recent issues and happening. It serves as a bridge between researchers from academia and industry enhanced by its well organized scientific sessions, plenary lectures, poster presentations, world-class exhibitions, diverse symposiums, highly enriched workshops and B2B meetings.

About Venue

Amsterdam is the capital of Netherlands. Amsterdam is a city that's rich in the visitor sights. It has many ancient churches and many magnificent museums as well. As the commercial capital of the Netherlands and one of the top financial centres in Europe. Amsterdam offers a lot more, like the world-class Van Gogh Museum, the Rijksmuseum and shopping on Nine Little Streets. Families may enjoy a visit to the NEMO Science Museum and Vondelpark. So pack your bag, pick up a camera and get ready for an adventure in Amsterdam!!

As the business capital of the Netherlands and one of the best budgetary focuses in Europe, Amsterdam is viewed as an alpha world city by the Globalization and World Cities (GaWC) ponder gathering. The city is likewise the social capital of the Netherlands. Numerous extensive Dutch organizations have their central command there, and seven of the world's 500 biggest organizations, including Philips and ING, are situated in the city. Amsterdam was positioned the second best city to live in by the Economist Intelligence Unit and the twelfth on nature of living for condition and foundation by Mercer. The city was positioned third in development by Australian advancement office in their Innovation Cities Index 2009. The Amsterdam seaport right up 'til the present time remains the second in the nation and the fifth biggest seaport in Europe. Well, known people groups of the Amsterdam are the diarist Anne Frank, craftsmen Rembrandt van Rijn and Vincent van Gogh, and thinker Baruch Spinoza.

Target Audience:

Business delegates

Industrial Leaders

Researchers

Modern gynaecologists

Eminent personalities 

Reputed scientists

Professors and Students from Academia

Doctors

Nurses

Nurse Practitioners

Students

Integrated Health Professionals

Industry Professionals

Health Promoters

EuroScicon is corporate members of the following organisations:

IBMS

Rare Care UK

Royal Society of Biology

British Society for Immunology

Opportunities for Conference Attendees

Sessions / Tracks

Track 1: Gynaecology and Obstetrics pathology

Gynaecologic and Obstetrics Pathology is the medical pathology subspecialty dealing with the study and diagnosis of disease involving the female genital tract, which includes vagina, ovaries, uterus and the breasts. Obstetrics Pathology is the study of diagnosis and diseases involve during pregnancy and childbirth, and the postpartum period. A physician who practices gynaecologic pathology is a gynaecologic pathologies. Laparoscopy Devices Market was valued at $9,350 million in 2015 and is expected to garner $14,046 million by 2022, registering a CAGR of 5.8% during the forecast period 2016 - 2022

• Principles and Practice of Oncology in Gynaecology
• Lactation Support
• Placenta - Development, Structure, Functions
• Basics of Breast Diseases related to obstetrics / gynaecology
• Pregnancy Care and Delivery

Track 2: Cosmo Gynecology Surgery

Track 3: Recent Advances in Gynaecology

The most common gynecological emergencies are ectopic pregnancy, acute pelvic inflammatory disease, miscarriages and complicated ovarian cysts. Other gynaecological conditions which may present as emergencies are menstrual disorders, bleeding gynecological malignancies, coital laceration and sexual assault. In the tropics, ectopic pregnancy and complications of unsafe abortion are the most common life threatening gynecological emergencies. Surgical devices captured largest market share in 2017 owing to rising use of endoscopy devices and female contraceptives. As a result, surgical devices segment was valued at USD 9,720.6 million in 2017 and is expected to reach USD 17,073.3 million by 2022.  This issue focuses on the recent advances that make important reading to the busy clinician on whom the up-grading of clinical skills is imperative and vital to the good practice of Obstetrics and Gyneco Recent innovations in population-level data collection and storage have made available an unprecedented amount of data for analysis while computational technology has evolved to permit processing of data previously thought too dense to study.

• Biology of the Ovary
• Medicated Intrauterine Devices
• Carcinoma of the Cervix
• Human Fetal Endocrines

Track 4: Medical Complication in Pregnancy

Complications of pregnancy are health problems that occur during pregnancy. They can involve the baby's health, the mother's health or both. Some women have health problems that arise during pregnancy, and other women have health problems before they become pregnant that could lead to complications. logistic regression analyses were used to compute odds ratios with 95% confidence intervals for age, race, medical conditions and events, and pregnancy-related complications among older women compared to younger women  as well as for women aged 35–44 compared to women younger than 35. To determine the effect of maternal age on medical and obstetric complications at delivery, a multivariable logistic regression model was created for the outcome of medical and obstetric complications among women aged 45 and older, or women aged 35–44, and each age group compared to women age less than 35, while controlling for pre-existing medical conditions, multiple gestation, and insurance status.

• Diabetes Mellitus
• Urinary Tract Infection
• Special care for mothers who are regular drinkers and smokers
• HIV
• Pelvic girdle pain
• Deep vein thrombosis

Track 5: Urogenital System of Human

The urethra is the tube that conveys pee from the bladder to the outside of the body. The female urethra is significantly shorter than its male partner and its opening is arranged between a lady vagina and clitoris. In case of guys this tube ventures to every part of the length of the penis. As per the most recent market report distributed by Credence Research, Include "Urinary Tract Infection Treatment Market – Growth, Future Prospects and Competitive Analysis 2017 – 2025 " the worldwide urinary tract disease (UTI) treatment showcase was esteemed about 21% in 2016, and is relied upon to achieve approx. 51% by 2025, extending at a CAGR of 3.2% from 2017 to 2025. North America (U.S. also, Canada)Latin America (Mexico, Brazil,  Chile, and others),Western Europe (Germany, U.K., France, Spain, Italy, Nordic nations, Belgium, Netherlands, and Luxembourg) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand),Eastern Europe (Poland and Russia),Middle East and Africa (GCC and Southern Africa)The worldwide urinary tract growth showcase is sectioned based on types treatment systems, demonstrative methods  and geology. Based on types urinary tract malignancy showcase is additionally sorted into, Squamous cell carcinoma, Urothelial carcinoma and Adenocarcinoma etc.

• Intravenous Pyelogram
• Chlorhexidine
• Neoplastic lesion
• Phenazopyridine
• Porphyrins          

Track 6: Gynaecological Endocrinology

Reproductive endocrinology and infertility (REI) is a surgical subspecialty of obstetrics and gynaecology that trains physicians in reproductive medicine addressing hormonal functioning as it pertains to reproduction as well as the issue of infertility. The global infertility treatment market is expected to rise at a CAGR of 10.6% during the forecast period 2016-2023.

• Colposcopy
• Paediatric and Adolescent Gynaecology
• Pregnancy and Diabetes
• Neuroendocrinology of Reproduction
• Reproductive Endocrinology

Track 7: Tubal Ligation

It is a surgical procedure for sterilization in which a woman's fallopian tubes are clamped and blocked or severed and sealed, either of which prevents eggs from reaching the uterus for implantation. Tubal ligation is considered a permanent method of sterilization and birth control. Tubal ligation (incorrectly referred to as tubectomy) is considered major surgery, typically requiring the patient to undergo local, general, or spinal anaesthesia. The global female sterilization procedures market is estimated to register a CAGR of 10% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the global female sterilization procedures market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. The report offers insightful and detailed information regarding the various key players operating in the global female sterilization procedures market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global female sterilization procedures market report has been segmented on the basis of procedure, type, and region.

• Pomeroy tubal ligation
• Adiana tubal ligation
• Bipolar coagulation
• Monopolar coagulation

Track 8: Minimally Invasive Gynaecologic Surgery

Gynaecological surgery refers to surgery on the female reproductive system. Gynaecological surgery is usually performed by gynaecologists. It includes procedures for benign conditions, cancer, infertility, and incontinence. Gynaecological surgery may occasionally be performed for elective or cosmetic purposes the research and development investments and therefore, improving the chances of diagnostic success. Owing to these factors, the global gynaecology devices revenue generated is expected to increase at a CAGR of 5.8% between 2016 and 2025. This market’s overall revenue generated is expected to increase from US$15.9 bn in 2014 to US$32.5 bn in 2025.

• Hysterectomy
• Laparoscopy
• Colposcopy
• Hysteroscopy
• Ablation
• Biopsy

It is the surgical removal of an ovary or ovaries. The surgery is also called ovariectomy, but this term has been traditionally used in basic science research to describe the surgical removal of ovaries in laboratory animals. Removal of the ovaries in women is the biological equivalent of castration in males; the term castration is only occasionally used in the medical literature to refer to oophorectomy in humans. Oophorectomy is most often performed because of diseases such as ovarian cysts or cancer. In five States in 2013, there were 65,900 hospital visits in which a hysterectomy, an oophorectomy, or both surgeries were performed. Of these surgeries, 60.4 per cent occurred in the outpatient setting. The rate of hysterectomy surgeries (across inpatient and ambulatory surgery settings) decreased 12.4 per cent from 2015 to 2017. The trend varied depending on whether an oophorectomy was performed at the same time the rate increased 14.8 per sent when hysterectomy was performed alone and decreased 29.4 per cent when the hysterectomy and oophorectomy were combined. The rate of oophorectomy alone decreased 11.9 per cent from 2015 to 2017.

• Endometriosis
• Cardiovascular risk
• Birth control
• Polycystic ovary syndrome

Track 10: Reproductive Medicine

Reproductive medicine is a branch of medicine that deals with prevention, diagnosis and management of reproductive problems; goals include improving or maintaining reproductive health and allowing people to have children at a time of their choosing. It is founded on knowledge of reproductive anatomy, physiology, and endocrinology, and incorporates relevant aspects of molecular biology, biochemistry and pathology. Europe is expected to emerge as a leading revenue contributor by 2022, with growth supported by the growing prevalence of infertility and rising demand for medical tourism. The fertility services market is expected to reach USD 8.9 billion by 2020, growing at a CAGR of over 8%

• Reproductive Endocrinology
• Neuroendocrinology of Reproduction
• Hysteroscopy
• Reproductive Cloning
• Biomarkers in Reproductive drugs
• Prenatal Diagnosis Using Three-Dimensional Ultrasound

Track 11: Urinary Incontinence (UI)

It also known as involuntary urination is any leakage of urine. It is a common and distressing problem, which may have a large impact on quality of life. It is twice as common in women as in men. Pelvic surgery, pregnancy, childbirth, and menopause are major risk factors. It has been identified as an important issue in geriatric health care. Urinary incontinence is often a result of an underlying medical condition but is under-reported to medical practitioners. It also known as involuntary urination is any leakage of urine. It is a common and distressing problem, which may have a large impact on quality of life. It is twice as common in women as in men. Pelvic surgery, pregnancy, childbirth, and menopause are major risk factors. It has been identified as an important issue in geriatric health care. Urinary incontinence is often a result of an underlying medical condition but is under-reported to medical practitioners. Urinary Incontinence (UI) is a medical condition in which a person urinates unconsciously. It can also be called as a leakage of urine without being conscious about it. There are certain types of UI such as Stress incontinence (leakage of urine due to pressure on bladder by sneezing, coughing, etc.), Urge incontinence (Strong urge of urination which leads to unconscious loss of urine), Overflow incontinence (constant dripping of urine due to the bladder which doesn’t get empty totally) and Mixed incontinence (patient suffering from more than one type of urinary incontinence). Depending on these types of incontinence, physicians prescribe specific treatments. Globally the market for Urinary Incontinence is growing steadily and has a bright future. Globally the market for Urinary Incontinence is expected to grow at the rate of about 3% to 4% from 2016 to 2022.

• Enuresis
• Stress incontinence
• Urge incontinence
• Functional incontinence
• Giggle incontinence

Track 12: Robotic Surgery in Gynecologic Oncology

Robotic surgery for the treatment of gynecologic cancers allows for less invasive surgical removal of tissues and cancer-bearing organs using sophisticated surgeon-manipulated, robotic surgical instrumentation. Approximately 84,000 women were diagnosed in the United States with gynecologic malignancies in 2017. Treatment typically involves major abdominal surgery to remove the primary cancer. The global surgical robot market size was valued at USD 4.9 billion in 2016and is expected to grow at a CAGR of 25.03% over the next 10 years.

• Robotic Surgery for Cervical Cancer
• Robotic Surgery for Endometrial Cancer
• Robotic Surgery for Ovarian Cancer
• Robotic Surgery in Anticipation of Radiation Therapy
• Robotic Surgery Costs for Oncologic Procedures

Track 12: Clinical Gynaecologic Oncology

Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of these cancers. The Cystoscopy market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance and others. Cystoscopy Market estimates have also been provided for the historical years 2013 & 2014 along with forecast for the period from 2015 – 2022.

• Cancer in Pregnancy
• Blood Component Therapy
• Diagnosis and Treatment
• Causes and Risk Factors

Track 14: Infertility

Infertility is the inability of a person, animal or plant to reproduce by natural means. It is usually not the natural state of a healthy adult, except notably among certain eusocial species the fertility in the US to grow at steadily a CAGR of around 6% by 2021. The fertility market in the US consists of fertility drugs and assisted reproductive technology (ART) services segments. Increasing fertility issues among the aging population, rising disposable income, growing adoption of fertility services by homosexual couples, and augmented support from the US federal government are some of the major factors that will impel growth in this market during the forecast period. The global infertility treatment market is expected to rise at a CAGR of 10.6% during the forecast period 2016-2023.

• Tubal Infertility and Ectopic Pregnancy
• Obesity & Surgical Management of Infertility
• Artificial Gametes and Ovarian Stimulation

Track 15: Midwifery

Midwifery, also known as obstetrics, is the health science and the health profession that deals with the reproductive genecology that includes pregnancy, childbirth, and the postpartum period (including care of the new-born), besides sexual and reproductive health of women throughout their lives. Midwifery-led continuity of care is where one or more midwives have the primary responsibility for the continuity of care for childbearing women, with a multidisciplinary network of consultation and referral with other health care providers. The actual duties of the midwife in obstetrics and genecology associates categories includes antiquity consisted mainly of assisting in the birthing process, although they may also have helped with other medical problems relating to women when needed The most well-known group of midwives are Certified Nurse Midwives (CNM’s). These midwives are registered nurses who have completed a nationally accredited graduate level program of study approved by the Accreditation Commission of Midwifery Education to become midwives. These midwives are not required to have health backgrounds before studying midwifery. Their education is usually a year or so in length after which they study as apprentices under other CPM’s or CNM's for experience. They achieve certification in midwifery through a different national exam, given by the North American Registry of Midwives. CPM’s tend to practice in out-of-hospital births, while CNM’s and CM’s often practice in hospitals but also attend birth Centre and home births. 95% of births by CNM’s occur in hospital.

• Midwifery Care
• Midwifery in Low Income Countries
• Recent Developments in Midwifery Research
• Midwifery in Multi-Ethnic Community

Track 16: Amenorrhea

Amenorrhea is the absence of a menstrual period in a woman of reproductive age. Physiological states of amenorrhea are seen, most commonly,   during pregnancy and lactation (breastfeeding), the latter also form the basis of a form of contraception known as the lactation amenorrhea method. Outside the reproductive years, there is absence of menses during childhood and after menopause Amenorrhea is a symptom with many potential causes. The physical examination may provide clues about the possible cause of amenorrhea. The examination in women with secondary amenorrhea should include measurements of height and weight. A body mass index (BMI) greater than 30 kg/m2 is observed in 50 per cent or more of women with PCOS, depending on the population studied. Women with a BMI less than 18.5 kg/m2 may have functional hypothalamic amenorrhea due to an eating disorder, strenuous exercise, or a systemic illness associated with weight loss. Many patients are deficient in their body stores of vitamin D, reflected by a serum 25-hydroxy vitamin D level less than 30 nmol/L. If this is the case, patients should be treated for 8-12 weeks with high-dose vitamin D, 50,000 IU/week, for repletion. Once the 25-OH-D level is greater than 30 nmol/L, 1000 IU/d of vitamin D may be instituted. Female sterilization procedure is a permanent way of preventing women from conceiving. Female sterilization acts as a method of birth control and is primarily used for family planning across the globe. It is an outpatient procedure performed by medical practitioner present in the hospitals and clinics. Post procedure complications are very rare and include bowel or bladder injury, infection, problems related to anesthesia, internal bleeding, and ectopic (tubal) pregnancy.

• Antipsychotics
• Thyroid malfunction
• Pituitary tumor
• Uterine scarring
• Osteoporosis

Track 17: Menopause

Menopause is termed as the stage of the end of the fertile phase in women which generally occurs at the age of 40 in almost 85% of women. Menopause results in reduced estrogen production and increased gonadotropin, resulting in the cessation of their menstrual cycle and menstrual flow. The market drivers for global menopause treatment market are rise in population, increasing awareness regarding women health, development of healthcare and gynecology Centre’s, and development in drugs especially the advancements in hormonal drugs etc. The market restraints are the complications of drug treatment such as osteoporosis, bleeding, high cost of treatment, etc. The global menopause treatment market is expected to reach USD 3.3 billion by 2023, and the market is projected to grow at a CAGR of ~ 4.2 % during the forecast period 2017-2023. Major drugs operating in the market in 2016 were Evista, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, Forteo, Premarin, Actonel, and Ortho-Tri-Cy LO 28. The market is expected to witness patent expiration in the coming years. However, presence of a drug pipeline for women’s health and recent approvals are likely to drive the market. For instance, in May 2017, TYMLOS (abaloparatide) received FDA approval for treatment of postmenopausal women with osteoporosis in the U.S. who are at high risk of developing fractures.

• Age at Menopause
• Premature Menopause
• The Immune System in Menopause
• Metabolic Transitions at Menopause
• Management of Menopause

Track 18: Polycystic Ovary Syndrome

The global polycystic ovarian syndrome treatment market size was valued at USD 3.9 billion in 2017 and is expected to grow at a CAGR of 5.0% over the forecast period. According to the research conducted by American Academy of Family Physicians, approximately 7% women of reproductive age are affected by Polycystic Ovary Syndrome (PCOS) in the U.S. The global polycystic ovarian syndrome treatment market is expected to reach USD 5.1 billion by 2025, according to a new report by Grand View Research, Inc. According to the Centers of Disease Control & Prevention, Polycystic Ovary Syndrome (PCOS) is the most common cause of female infertility. Approximately 6% to 12% women of reproductive age suffer from PCOS in the U. S. Moreover, progression of this condition can lead to metabolic abnormalities, which may result in development of type 2 diabetes, if the syndrome is not treated on time. The severity of the disorder increases the risk of developing uterine and endometrial cancers in patients. Thus, early diagnosis and effective treatment are significant for successful recovery. The hospital pharmacies segment is estimated to account for 48.3% market share by 2016, which is anticipated to increase to 49.8% by 2024.This segment is expected to continue to lead the market in terms of revenue growth. The E-commerce segment is estimated to be valued at US$ 118.8 Mn by 2016 and is expected to expand at a CAGR of 4.3%.

• Polycystic ovaries
• Menstrual irregularity
• Acanthosis nigricans
• Dyslipidaemia

Track 19: Normal Pregnancy, Labour & Puerperium

A control group of 8157 (35.17%) normal weight pregnant women at term (BMI 18-24.9) was compared to the three populations with increased BMI at term for maternal demographic and obstetric variables. Overweight and obese women were significantly older (5.42% vs. 8.11%and 7.7%, p 0.000), pluriparous (46.35% vs. 50.97%, p0.000), and high school graduated (65.83% vs. 74.01%), overweight and obese women had higher incidence of the study involved 13 post-partum women who had delivered per vagina within the last two months. They were aged 18 to 35 years and were all Christians. With the exception of one participant, all the women were married.

• Routine Postpartum Care
• Perineum
• Signs of placental separation

Track 20: Sexual and Reproductive Health Rights

25% of married girls (15-19 years) with an unmet, need for family planning, 50% of unsafe abortions in Africa that occur among married and unmarried girls and young women (15-24 years). 1000 Number of young girls and young boys (15-24 years) who become infected with Human influenza virus every day. 60%Percentage of unsafe abortions in Africa that occur among married and unmarried girls and young women (15-24 years) Sexual and reproductive health research in low and middle-income countries faces several key challenges in achieving high-quality research and publications. Often, the research is underfunded, emerging institutions lack visibility and networking opportunities, there are few training opportunities for individuals and grant termination leads to inability to conduct or continue independent research.

• SRHR and Education
• SRHR and Economic Benefits
• SRHR and Broader Health Agenda
• Safe Sex Tips Contraception, or Sterilization

Market Report

EuroScicon invites participants from across the globe to join the “Annual Conference on Gynaecology, Obstetrics & Reproductive Health” going to be held during August 23-24, 2018,  Amsterdam, Netherlands. The conference includes Keynote Presentations, Oral Talks, Poster Presentations, Product Launches and Exhibitions. Euro Gynecology 2018 is a specially designed cluster conference, whose main theme is “Technical Strategies in Pre-natal grief, Child Birth and Congenital Disorders”. This event covers a wide spectrum of critically important sessions.

For more details please visit: https://gynecology.euroscicon.com/

Learn More

Major Gynecology and Obstetrics Associations around the Globe:

Related Associations and Societies in Gynecology and Obstetrics.

In the Netherlands everyone must have health insurance and be registered with a general practitioner. There are very few private practices for gynaecologists so you will need to be properly registered for a referral from your GP.

List of Top Hospitals in World:

An Obstetrician / Gynecologist (OB/GYN) earns an average salary of $195700 per year in USA. In 2016 obstetricians and gynecologists earned a mean income of $220000 somewhat less than in the previous year. About 20% of ob/gyns earned $350000 or more slightly more than in last year's survey. Some 19% earned $100000 or less up from about 12% the previous year. Solo practitioners earned 93% of income from clinical practice compared to 89% for group practice ob-gyns. Those in group practice derived significantly greater percentages of income from teaching/research and other professional activities.

Market report “Gynecological Devices Market” by Surgical Device (Gynecological Endoscopy Devices Endometrial Ablation Devices Fluid Management Systems and Female Sterilization and Contraceptive Devices) by Hand Instrument (Vaginal Speculum Tenaculum Curettes Trocars Biopsy Forceps and Others) and by Diagnostic Imaging System (Ultrasound and Mammography) Global Industry Perspective Comprehensive Analysis and Forecast 2016 -2021”. According to the report the global gynecological devices market accounted for around USD 15.50 billion in 2016 and is expected to reach approximately USD 20.00 by 2021 growing at a CAGR of around 5.0% between 2016 and 2021. 

A gynecologist is a general practitioner with special learning and proficiency in the field of women’s' health and reproduction.  A gynecologist has the appropriate medical surgical and obstetrical knowledge and skills for the prevention diagnosis and management of a wide range of conditions that affect women's reproductive and gynecological health. The specialty of obstetrics and gynecology can be divided into two parts. Obstetrics concentrates on the care and treatment before and during pregnancy and after the child is born. Gynecology is concerned with the treatment of diseases and disorders of the female reproductive system. Various devices such as gynecology endoscopy device ultrasound sonography and vaginal speculum are some of the common devices used during obstetrics and gynecological practice.

The global market for gynecological devices features a highly fragmented vendor landscape with the leading three companies namely Olympus Corporation Boston Scientific Corporation and Cooper Surgical accounted for over 25.5% of the market’s overall revenue in 2014 observes Transparency Market Research in a recent report. Although regional players and new vendors account for a significant share in the market’s revenue presently entry barriers are becoming more intense for new companies. Increasingly stringent slow and expensive regulatory approval procedures are increasing operational challenges for companies in the market.

Research estimates that the global gynecological devices market will exhibit a healthy CAGR of 4.9% over the period between 2016 and 2023 and rise from a valuation of US$14.9 bn in 2016 to US$23.5 bn by 2023.

Some of the key factors driving the global market for gynecological devices are the rising prevalence of a number of gynecological disorders the increased adoption of non-invasive or minimally invasive gynecological procedures and the increase in healthcare expenditure across emerging economies. Owing to the presence of a large number of companies and the intense level of competition in the market focus on R&D activities and the increased energy directed towards the introduction of innovative devices are leading to the development of highly advanced and reliable noninvasive devices for the gynecological devices sector.

Increase in healthcare expenditure especially across emerging economies in regions such as Asia Pacific and Latin America is also providing significant boost to the overall demand for gynecological devices in the region. Continued efforts aimed at the improvement of the healthcare infrastructure in these regions will also boost the demand for advanced gynecological devices in the near future.

This analytical overview of the market is based on a recent Transparency Market Research report titled “Gynecological Devices Market” (Surgical Devices (Gynecological Endoscopes (Hysteroscopy Colposcopes Resectoscopes Laparoscopes and Endoscopic Imaging Systems) Endometrial Ablation Devices (Hydrothermal Endometrial Ablation Devices Radiofrequency Endometrial Ablation Devices Balloon Endometrial Ablation Devices Cryoablation Microwave Ablation and Laser Ablation) Female Sterilization and Contraceptive Devices (Permanent Birth Control Devices and Temporary Birth Control Devices) and Gynecologic Fluid Management Systems; Hand Instruments (Vaginal Speculum (Disposable and Reusable) Tenaculum Curettes Trocars and Biopsy Forceps); Diagnostic Imaging Systems (Ultrasound and Mammography); and Gynecological Chairs (Fixed Height and Adjustable)) - Global Industry Analysis Size Share Growth Trends and Forecast 2016 - 2023.”

Global Gynecological Devices Market by Geography:

Amsterdam: The Women's Healthcare Center (WHC) is an independent treatment center (ITC) for gynecology obstetrics sexology urology and echography. In addition care is offered for the sub-specialisms urogynecology and gynecardiology. The WHC is located in Amsterdam in the Buitenveldert district. Besides from Amsterdam and its surrounding areas the clinic treats patients from the whole country. Compared to other countries the Netherlands has a low abortion rate. Abortions are legal here and are performed as outpatient surgery at licensed clinics and hospitals until approximately 24 weeks into pregnancy. Though abortions are rarely performed after 22 weeks. Your GP will refer you to a specialist for which your health insurance company will cover you. This being the case you may be required to answer a series of questions per policy protocol. According to Randstad it’s estimated that approximately 40% of Dutch women aged 15-30 use the pill. Another 5-10% of patients also use IUDs but diaphragms are the least popular choice of birth control methods.

Industry Insights

The global gynecology devices market size was valued at USD 10984.1 million in 2014. Introduction of minimally invasive procedures such as laparoscopy and high definition imaging devices such as 3D endoscope is primarily boosting market growth. In addition rising prevalence of diseases such as uterine fibrosis and sexually transmitted diseases (STDs) associated with female reproductive organs are anticipated to support market growth during the forecast period.

According to the United Nations the global female population accounted for more than 3.64 billion in 2015. Every woman visits a gynecologist at least once in her lifetime either for pregnancy or other complications related to menstrual cycle. The growing number of patients is likely to drive market growth during the forecast period.

Moreoverhealthcare agencies are now promoting routine-checkups for early cancer detection and other gynecological conditions. For example The American Cancer Society recommends annual breast cancer screening with mammography for women aged between 40 to 44 years. Increase in routine check-ups has helped these devices gain usage rates.

Furthermore the introduction of user friendly and technically advanced products has augmented the adoption of surgical procedures such as laparoscopy ablation endoscopy and female sterilization. To conclude the availability of technically advanced products coupled with rising adoption of surgical procedures is steering the global gynecological devices market towards experiencing swift growth.